Trials / Completed
CompletedNCT00338793
Corticosteroids in the Treatment of Tuberculous Pleurisy
A Multicenter, Placebo-Controlled, Double-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Corticosteroids for Treatment of Patients With Tuberculous Pleurisy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (estimated)
- Sponsor
- Guangxi Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tuberculous pleurisy is associated with inflammation and fibrosis. Adjunctive corticosteroids are used for tuberculous pleurisy because their anti-inflammatory effect is thought to minimise pleural reactivity and thereby reduce residual pleural thickening. The purpose is to evaluate the efficacy and safety of oral prednisolone for treatment of adult patients with tuberculous pleurisy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisolone |
Timeline
- Start date
- 2006-07-01
- Completion
- 2008-08-01
- First posted
- 2006-06-20
- Last updated
- 2008-08-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00338793. Inclusion in this directory is not an endorsement.